S
Steffen Schneider
Researcher at Heidelberg University
Publications - 202
Citations - 13129
Steffen Schneider is an academic researcher from Heidelberg University. The author has contributed to research in topics: Myocardial infarction & Cardiogenic shock. The author has an hindex of 43, co-authored 199 publications receiving 11184 citations. Previous affiliations of Steffen Schneider include University of Giessen & Leipzig University.
Papers
More filters
Journal ArticleDOI
Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock
Holger Thiele,Uwe Zeymer,Franz-Josef Neumann,Miroslaw Ferenc,Hans-Georg Olbrich,Jörg Hausleiter,Gert Richardt,Marcus Hennersdorf,Klaus Empen,Georg Fuernau,Steffen Desch,Ingo Eitel,Rainer Hambrecht,Jörg Fuhrmann,Michael Böhm,Henning Ebelt,Steffen Schneider,Gerhard Schuler,Karl Werdan +18 more
TL;DR: The use of intraaortic balloon counterpulsation did not significantly reduce 30-day mortality in patients with cardiogenic shock complicating acute myocardial infarction for whom an early revascularization strategy was planned.
Journal ArticleDOI
Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial
Holger Thiele,Uwe Zeymer,Franz-Josef Neumann,Miroslaw Ferenc,Hans-Georg Olbrich,Jörg Hausleiter,Antoinette de Waha,Gert Richardt,Marcus Hennersdorf,Klaus Empen,Georg Fuernau,Steffen Desch,Ingo Eitel,Rainer Hambrecht,Bernward Lauer,Michael Böhm,Henning Ebelt,Steffen Schneider,Karl Werdan,Gerhard Schuler +19 more
TL;DR: In patients undergoing early revascularisation for myocardial infarction complicated by cardiogenic shock, IABP did not reduce 12 month all-cause mortality.
Journal ArticleDOI
PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock
Holger Thiele,Ibrahim Akin,Marcus Sandri,Georg Fuernau,Suzanne de Waha,Roza Meyer-Saraei,Peter Nordbeck,Tobias Geisler,Ulf Landmesser,Carsten Skurk,Andreas Fach,Harald Lapp,Jan J. Piek,Marko Noc,Tomaž Goslar,Stephan B. Felix,Lars S. Maier,Janina Stępińska,Keith G. Oldroyd,Pranas Šerpytis,Gilles Montalescot,Olivier Barthelemy,Kurt Huber,Stephan Windecker,Stefano Savonitto,Patrizia Torremante,Christiaan J. Vrints,Steffen Schneider,Steffen Desch,Uwe Zeymer +29 more
TL;DR: Among patients who had multivessel coronary artery disease and acute myocardial infarction with cardiogenic shock, the 30‐day risk of a composite of death or severe renal failure leading to renal‐replacement therapy was lower among those who initially underwent PCI of the culprit lesion only than amongThose who underwent immediate multivessels PCI.
Journal ArticleDOI
OMEGA, a Randomized, Placebo-Controlled Trial to Test the Effect of Highly Purified Omega-3 Fatty Acids on Top of Modern Guideline-Adjusted Therapy After Myocardial Infarction
Bernhard Rauch,Rudolf Schiele,Steffen Schneider,Frank Diller,Norbert Victor,Helmut Gohlke,Martin Gottwik,Gerhard Steinbeck,Ulrike Del Castillo,Rudolf Sack,Heinrich Worth,Hugo A. Katus,Wilhelm Spitzer,Georg V. Sabin,Jochen Senges +14 more
TL;DR: In this article, the effects of omega-3-acid ethyl esters-90 (1 g/d for 1 year) on the rate of sudden cardiac death in survivors of acute myocardial infarction was investigated.
Journal ArticleDOI
Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years.
Thomas Kleemann,Torsten Becker,Klaus Doenges,Margit Vater,Jochen Senges,Steffen Schneider,Werner Saggau,U Weisse,Karlheinz Seidl +8 more
TL;DR: An increasing annual lead failure rate is noted primarily during long-term follow-up and reached 20% in 10-year-old leads during the present study.